Gyre Therapeutics Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.47

+0.40 (+5.66%)

As of May 10, 10:16 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +300.5% upside

Low Target $20.05

Average Target $29.92

High Target $33.42

Current Price $7.47

Current
$7.47

Target
$29.92

$20.05 $29.92 avg $33.42

Scenario Analysis

Bear Case

$20.05

168.4%

Low target

Base Case

$29.92

+300.5%

Avg target

Bull Case

$33.42

+347.4%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$11.78

-36.6% from high

52-Week Low

$6.57

+13.7% from low

Target vs 52W High

$29.92

+154.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%